Pfizer – CHANGING TIMES

Tag: Pfizer

Covid-19: as billions are vaccinated, adverse effects and virus variants cause concern

By Annette Gartland on February 8, 2021

This article has been updated. Latest update 3/7/2022. Statistics from the adverse event databases have been updated along with the sections about India, about vaccinating children and adolescents, about variants, and about […]

Covid-19: vaccine race front runners rush to obtain emergency use authorisations

By Annette Gartland on December 12, 2020

This is a rejigged and updated version of an earlier article. Latest update: 29/1/2021. The FDA in the US has issued emergency use authorisations for the Pfizer-BioNTech and Moderna vaccines. The Pfizer-BioNTech […]

Covid-19: as companies vaunt vaccine trial results, concerns mount over fast tracking

By Annette Gartland on November 25, 2020

This article has been updated. Latest update: 11/12/2020. The Pfizer/BioNTech vaccine is now being given to members of the public in the UK under emergency use authorisation. The elderly are being prioritised. […]

Covid-19: concerns increase over fast tracking as SARS-CoV-2 vaccine race accelerates (audio digest)

By Annette Gartland on November 11, 2020

Covid-19: concerns increase over fast tracking as SARS-CoV-2 vaccine race accelerates

By Annette Gartland on October 26, 2020

This is a rejigged and updated version of an earlier article. Audio digest of this article (not updated). See article for the latest announcements by Pfizer/BioNTech, Moderna, AstraZeneca, and the developers of […]

Covid-19: concerns mount over fast tracking as SARS-CoV-2 vaccine race accelerates

By Annette Gartland on September 9, 2020

This article has been updated with the news that AstraZeneca has resumed trials of AZD1222 and with information about the pausing of Johnson & Johnson’s vaccine trial. A rejigged, updated version of […]